Remarkable Regression of Massive Deep Vein Thrombosis in Response to Intensive Oral Rivaroxaban Treatment

Thrombosis Journal - United Kingdom
doi 10.1186/s12959-015-0045-1
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Patient Adherence to Rivaroxaban in Deep Vein Thrombosis, a Cohort Study in Switzerland: Quantitative Results

International Journal of Clinical Pharmacy
ToxicologyPharmacyPharmacologyPharmaceutical Science
2019English

Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939): The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) Study

Circulation
Cardiovascular MedicinePhysiologyCardiology
2007English

Sub-Massive Pulmonary Thromboembolism With Out Deep Vein Thrombosis

Indian Journal of Cardiovascular Disease in Women WINCARS
2016English

Deep Vein Thrombosis

JAMA - Journal of the American Medical Association
Medicine
2015English

Deep Vein Thrombosis

AAOHN Journal
2008English

Subcutaneous or Intravenous Heparin in Treatment of Deep Vein Thrombosis

BMJ
1987English

Deep Vein Thrombosis. Diagnosis.

BMJ
1969English

Editorial: Endovascular Treatment for Acute Proximal Deep Vein Thrombosis

Journal of Cardiology Cases
Cardiovascular MedicineCardiology
2015English

Improving Deep Vein Thrombosis Prophylaxis With Mechanical Modalities in Surgical Intensive Care Unit

Journal of Nursing Care Quality
Nursing
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy